title: Should third-generation cephalosporins be avoided against AmpC-inducible Enterobacteriaceae?
authors.forename: David M
authors.initials: DM
authors.lastname: Livermore
authors.forename: Derek F J
authors.initials: DF
authors.lastname: Brown
authors.forename: John P
authors.initials: JP
authors.lastname: Quinn
authors.forename: Yehuda
authors.initials: Y
authors.lastname: Carmeli
authors.forename: David L
authors.initials: DL
authors.lastname: Paterson
authors.forename: Victor L
authors.initials: VL
authors.lastname: Yu
mesh_terms: D018550:Cephalosporin Resistance; D002510:Cephalosporinase / Q000096:biosynthesis*; D002511:Cephalosporins / Q000494:pharmacology / Q000627:therapeutic use*; D004755:Enterobacteriaceae / Q000187:drug effects* / Q000201:enzymology*; D004756:Enterobacteriaceae Infections / Q000188:drug therapy*; D004790:Enzyme Induction; D006801:Humans
chemical_list: D002511:Cephalosporins; D002510:Cephalosporinase